BNY Mellon Emerging Markets Equity ETF (BKEM)
Live price chart, market sentiment, and community perspectives for BNY Mellon Emerging Markets Equity ETF (AMEX: BKEM).
Live price chart, market sentiment, and community perspectives for BNY Mellon Emerging Markets Equity ETF (AMEX: BKEM).
On our desk, we are monitoring the sharp 142.8% spike in short interest during July, which brought short totals to 25,024 shares. Even with a low days-to-cover ratio of 1.7 days, this sudden accumulation of short positions signals growing tactical skepticism among market participants who are wary of the fund's recent pullback from its all-time highs.
As a hedge fund portfolio manager, I find BKEM's underlying valuation compelling. Trading at an undemanding 13.1 P/E multiple driven by single-digit forward multiples in its top Korean memory holdings, the ETF offers a concentrated backdoor play on Asian technology and the ongoing AI memory cycle.
From a risk management standpoint, the fund's low asset base—hovering around $74M to $88M depending on the exact tracking period—presents a structural bottleneck. With average daily volumes often under 15,000 shares, execution risk is magnified by wider bid-ask spreads, making large reallocations challenging without causing unintended market impact.
From an institutional perspective, the cost profile remains one of BKEM's strongest selling points. Sub-adVISED by Mellon Investments Corporation, the fund maintains a gross and net expense ratio of just 0.11%, placing it among the most aggressively priced options in the diversified emerging markets category.
Looking at quantitative indicators, the technical profile is currently mixed. The ETF is trading roughly 3% below its 50-day moving average and more than 10% off its recent all-time highs, signaling that near-term momentum has cooled significantly despite respectable risk-adjusted long-term returns.
Our quantitative desk notes that BKEM functions effectively as a rules-based, cap-weighted bet on emerging market large and mid-caps, tracking the Solactive GBS Emerging Markets Large and Mid Cap USD Index very tightly. However, prospective buyers need to factor in the aggressive volatility profile tied directly to its tech-heavy sub-allocations.
Explore plasma cleansing, somatic organ swaps, and BCI.